PMID- 26956917 OWN - NLM STAT- MEDLINE DCOM- 20170103 LR - 20181113 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 6 DP - 2016 Mar 9 TI - Interleukin-31 expression and relation to disease severity in human asthma. PG - 22835 LID - 10.1038/srep22835 [doi] LID - 22835 AB - Interleukin 31 (IL-31) is a novel T helper type 2 effector cytokine that plays an important role in the pathogenesis of allergic diseases. However, its role in human asthma remains unclear. The aim of this study was to measure IL-31 levels in the serum, bronchoalveolar lavage fluid (BALF) and bronchial tissue of asthmatics and healthy subjects, and identify its possible correlation to disease severity. We quantified IL-31 levels in the serum of patients with asthma (n = 44), as well as in controls (n = 22). Of these subjects, 9 asthmatics and five controls underwent bronchoscopy with endobronchial biopsy and BALF collection. Our data showed that serum and BALF IL-31 levels were significantly elevated in patients with asthma compared with controls. Expressions of IL-31 and IL-31 receptor (IL-31RA and OSMR) were more prominent in the bronchial tissue in severe compared to mild asthma and controls. Serum IL-31 levels correlated positively with Th2 related cytokines (IL-5, IL-13, and TSLP), asthma severity or total serum immunoglobulin E (IgE), and inversely with asthma control and the forced expiratory volume in 1 second (FEV1). The current data may provide insight into the underlying pathogenesis of asthma, in which IL-31 has an important pathogenic role. FAU - Lai, Tianwen AU - Lai T AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Wu, Dong AU - Wu D AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Li, Wen AU - Li W AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Chen, Min AU - Chen M AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Yi, Zhennan AU - Yi Z AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Huang, Dan AU - Huang D AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Jing, Zhiliang AU - Jing Z AD - Department of pathology, Affiliated Hospital, Guangdong Medical College, Zhanjiang, China. FAU - Lu, Yingying AU - Lu Y AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Lv, Quanchao AU - Lv Q AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Li, Dongming AU - Li D AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. FAU - Wu, Bin AU - Wu B AD - Department of Respiratory and Critical Care Medicine, Affiliated Hospital, Institute of Respiratory Diseases, Guangdong Medical College, Zhanjiang, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160309 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (IL31 protein, human) RN - 0 (Interleukins) SB - IM MH - Adult MH - Asthma/*pathology MH - Blood Chemical Analysis MH - Bronchi/chemistry MH - Bronchoalveolar Lavage Fluid/chemistry MH - Female MH - Humans MH - Interleukins/*analysis/*blood MH - Male MH - Middle Aged MH - Respiratory Mucosa/chemistry PMC - PMC4783779 EDAT- 2016/03/10 06:00 MHDA- 2017/01/04 06:00 PMCR- 2016/03/09 CRDT- 2016/03/10 06:00 PHST- 2015/10/09 00:00 [received] PHST- 2016/02/19 00:00 [accepted] PHST- 2016/03/10 06:00 [entrez] PHST- 2016/03/10 06:00 [pubmed] PHST- 2017/01/04 06:00 [medline] PHST- 2016/03/09 00:00 [pmc-release] AID - srep22835 [pii] AID - 10.1038/srep22835 [doi] PST - epublish SO - Sci Rep. 2016 Mar 9;6:22835. doi: 10.1038/srep22835.